169 related articles for article (PubMed ID: 16236493)
1. Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens.
Sammour MB; el-Kabarity H; Fawzy MM; Schindler AE
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):439-40. PubMed ID: 16236493
[TBL] [Abstract][Full Text] [Related]
2. Present and future aspects of dydrogesterone in prevention or treatment of pregnancy disorders: an outlook.
Schindler AE
Horm Mol Biol Clin Investig; 2016 Aug; 27(2):49-53. PubMed ID: 27662647
[TBL] [Abstract][Full Text] [Related]
3. Successful prevention of preeclampsia in a high-risk pregnancy using progestogen dydrogesterone: a clinical case.
Tskhay VB; Kovtun NM; Schindler AE
Horm Mol Biol Clin Investig; 2016 Sep; 27(3):85-8. PubMed ID: 27383893
[TBL] [Abstract][Full Text] [Related]
4. Review on role of progestogen (dydrogesterone) in the prevention of gestational hypertension.
Mohamad Razi ZR; Schindler AE
Horm Mol Biol Clin Investig; 2016 Aug; 27(2):73-6. PubMed ID: 27101553
[TBL] [Abstract][Full Text] [Related]
5. Dydrogesterone support following assisted reproductive technique (ART) reduces the risk of pre-eclampsia.
Ali AB; Ahmad MF; Kwang NB; Shan LP; Shafie NM; Omar MH
Horm Mol Biol Clin Investig; 2016 Sep; 27(3):93-6. PubMed ID: 26910749
[TBL] [Abstract][Full Text] [Related]
6. Progestogens for treatment and prevention of pregnancy disorders.
Schindler AE
Horm Mol Biol Clin Investig; 2010 Dec; 3(3):453-60. PubMed ID: 25961219
[TBL] [Abstract][Full Text] [Related]
7. Dydrogesterone and the immunology of pregnancy.
Raghupathy R; Szekeres-Bartho J
Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
[TBL] [Abstract][Full Text] [Related]
8. A pilot study to determine whether progestogen supplementation using dydrogesterone during the first trimester will reduce the incidence of gestational hypertension in primigravidae.
Zainul Rashid MR; Lim JF; Nawawi NH; Luqman M; Zolkeplai MF; Rangkuty HS; Mohamad Nor NA; Tamil A; Shah SA; Tham SW; Schindler AE
Gynecol Endocrinol; 2014 Mar; 30(3):217-20. PubMed ID: 24552449
[TBL] [Abstract][Full Text] [Related]
9. New data about preeclampsia: some possibilities of prevention.
Schindler AE
Gynecol Endocrinol; 2018 Aug; 34(8):636-637. PubMed ID: 29508649
[TBL] [Abstract][Full Text] [Related]
10. Role of progestogens for the prevention of premature birth.
Schindler AE
J Steroid Biochem Mol Biol; 2005 Dec; 97(5):435-8. PubMed ID: 16198556
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity.
Awwad J; Usta IM; Ghazeeri G; Yacoub N; Succar J; Hayek S; Saasouh W; Nassar AH
BJOG; 2015 Jan; 122(1):71-9. PubMed ID: 25163819
[TBL] [Abstract][Full Text] [Related]
12. Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.
Romero R; Stanczyk FZ
Am J Obstet Gynecol; 2013 Jun; 208(6):421-6. PubMed ID: 23643669
[No Abstract] [Full Text] [Related]
13. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
Odibo AO; Stamilio DM; Macones GA; Polsky D
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):492-9. PubMed ID: 16946206
[TBL] [Abstract][Full Text] [Related]
14. Does progesterone treatment influence risk factors for recurrent preterm delivery?
Meis PJ; Klebanoff M; Dombrowski MP; Sibai BM; Leindecker S; Moawad AH; Northen A; Iams JD; Varner MW; Caritis SN; O'Sullivan MJ; Miodovnik M; Leveno KJ; Conway D; Wapner RJ; Carpenter M; Mercer B; Ramin SM; Thorp JM; Peaceman AM; Gabbe S
Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587
[TBL] [Abstract][Full Text] [Related]
15. Effects of dydrogesterone on the vascular system.
Seeger H; Mueck AO
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():2-8. PubMed ID: 17943533
[TBL] [Abstract][Full Text] [Related]
16. Dydrogesterone and pre-term birth.
Hudic I; Schindler AE; Szekeres-Bartho J; Stray-Pedersen B
Horm Mol Biol Clin Investig; 2016 Sep; 27(3):81-3. PubMed ID: 26812800
[TBL] [Abstract][Full Text] [Related]
17. Short- and long-term strategies for the management of hypertensive disorders of pregnancy.
Huda SS; Freeman DJ; Nelson SM
Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1581-94. PubMed ID: 19954320
[TBL] [Abstract][Full Text] [Related]
18. Is 17α-hydroxyprogesterone caproate contraindicated in twin gestations?
Romero R; Conde-Agudelo A
BJOG; 2015 Jan; 122(1):6-7. PubMed ID: 25280114
[No Abstract] [Full Text] [Related]
19. The role of progestogen supplementation (dydrogesterone) in the prevention of preeclampsia.
Tskhay V; Schindler A; Shestakova M; Klimova O; Narkevich А
Gynecol Endocrinol; 2020 Aug; 36(8):698-701. PubMed ID: 31876197
[TBL] [Abstract][Full Text] [Related]
20. Regulation of progesterone signaling during pregnancy: implications for the use of progestins for the prevention of preterm birth.
Byrns MC
J Steroid Biochem Mol Biol; 2014 Jan; 139():173-81. PubMed ID: 23410596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
